Matches in Nanopublications for { ?s ?p "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP645373.RAA93x6uKIGV6jXMXrjAKxrwxjIjuq59rIXnkipbUL9Vo130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645373.RAA93x6uKIGV6jXMXrjAKxrwxjIjuq59rIXnkipbUL9Vo130_provenance.
- NP923221.RAWtWYaSL_aJpypFNHhhSbOQMXaEOEgwfypOLLg-X0MWY130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923221.RAWtWYaSL_aJpypFNHhhSbOQMXaEOEgwfypOLLg-X0MWY130_provenance.
- NP918939.RAZCyY_wSY6yVd2QBY3neQRonZnGK-SBIS8Q5qRSiQM0U130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918939.RAZCyY_wSY6yVd2QBY3neQRonZnGK-SBIS8Q5qRSiQM0U130_provenance.
- NP649826.RA0JRl9_Em425kBKOclrMv09vXqYALl71_4B0KgTr05Xk130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649826.RA0JRl9_Em425kBKOclrMv09vXqYALl71_4B0KgTr05Xk130_provenance.
- assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657334.RAVDp6OAG5iorhMTupCOZoEMI7VZ0P36-ZRG59Xp7s17M130_provenance.
- NP918934.RA2u6bRRgPVutJ_pCj9lxuQUYy_jwZucE2FPHB5cccBGw130_assertion description "[Nucleotide sequencing of the highly conserved SMPD3 gene in a large panel of human cancers revealed mutations in 5 (5%) of 92 acute myeloid leukemias (AMLs) and 8 (6%) of 131 acute lymphoid leukemias (ALLs), but not in other tumor types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918934.RA2u6bRRgPVutJ_pCj9lxuQUYy_jwZucE2FPHB5cccBGw130_provenance.